AVM v1, released 02-OCT-22

A manually curated database of aerosol-transmitted virus mutations, human diseases, and drugs

Mutation detail:


Mutation site L30R
Virus Influenzavirus A H1N1
Mutation level Amino acid Level
Gene/protein/region type PB1
Gene ID 23308122
Country China
Mutation type nonsynonymous mutation
Genotype/subtype/clade -
Sample Human
Variants -
Viral reference sequence CY010794.1
Drug/antibody/vaccine -
Transmissibility -
Transmission mechanism -
Pathogenicity -
Pathogenicity mechanism -
Immune escape mutation -
Immune escape mechanism -
RT-PCR primers probes -

Protein detail:


Protein name Polymerase PB1
Uniprot protein ID C3W5X7
Protein length 757 amino acids
Protein description RNA-dependent RNA polymerase which is responsible for replication and transcription of virus RNA segments. The transcription of viral mRNAs occurs by a unique mechanism called cap-snatching. 5' methylated caps of cellular mRNAs are cleaved after 10-13 nucleotides by PA. In turn, these short capped RNAs are used as primers by PB1 for transcription of viral mRNAs. During virus replication, PB1 initiates RNA synthesis and copy vRNA into complementary RNA (cRNA) which in turn serves as a template for the production of more vRNAs

Literature information:


Pubmed ID 21483816
Clinical information No
Disease -
Published year 2011
Journal PLoS One
Title Reassortment and mutations associated with emergence and spread of oseltamivir-resistant seasonal influenza A/H1N1 viruses in 2005-2012
Author Ji-Rong Yang,Yu-Cheng Lin,Yuan-Pin Huang,Chun-Hui Su,Je Lo
Evidence The dominant variant acquired additional substitutions, including A206T in HA, H275Y and D354G in NA, L30R and H41P in PB1-F2, and V411I and P453S in basic polymerase 2 (PB2) proteins and subsequently caused the 2008-2011 influenza epidemic in Taiwan, accompanying the widespread oseltamivir-resistant viruses.